Recurrent venous thromboembolism in a Spanish population: Incidence, risk factors, and management in a hospital setting

Thrombosis Research

Volumn 96, Issue 5, 1999, Pages 335-341

  Grau, Enric ^a   Real, Esperanza ^a   Medrano, Jose ^a   Pastor, Emilio ^a   Selfa, Salvador ^a  

^a HOSPITAL LLUÍS ALCANYÍS   (Spain)

Author keywords

Incidence; Rethrombosis; Risk factors; Treatment; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; FEMALE; HEMOSTASIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SPAIN; THROMBOPHILIA; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; THROMBOEMBOLISM; THROMBOPHILIA; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0032796282     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00121-8     Document Type: Article

References (27)

1. Anderson F.A. Jr., Wheeler H.B., Goldberg R.J., Hosmer D.W., Patwardhan N.A., Jovanovic B., Forcier A., Dalen J.E. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study Arch Intern Med. 151:1991;933-938.
2. Kniffin W.D., Baron J.A., Barret J., Birkmeyer J.D., Anderson F.A. Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 154:1994;861-866.
3. De Stefano V., Finazzi G., Mannucci P.M. Inherited thrombophilia. Pathogenesis, clinical syndromes and management. Blood. 87:1996;3531-3544.
4. Clark S. Current issues in management of thrombosis. Lancet. 346:1995;113-114.
5. Ginsberg J.S. Management of venous thromboembolism. N Engl J Med. 335:1996;1816-1828.
6. Meissner M.H., Caps M.T., Bergelin R.O., Manzo R.A., Strandness D.E. Propagation, rethrombosis and new thrombus formation after acute deep venous thrombosis. J Vasc Surg. 22:1995;558-567.
7. Kakkar V.V., Lawrence D. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study Am J Surg. 150:1985;54-63.
8. Hull R.D., Raskob G.E., Pineo G.F. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med. 326:1992;975-982.
9. Holm H.A., Finnanger B., Hartmann A. Heparin treatment of deep venous thrombosis in 280 patients. Symptoms related to dosage Acta Med Scand. 215:1984;47-53.
10. Koopman M.M., Buller H.R., ten Cate J.W. Diagnosis of recurrent deep vein thrombosis. Haemostasis. 25:1995;49-57.
11. Hirsh J., Fuster V. AHA Medical/Scientific Statement. Special Report. Guide to anticoagulant therapy. Pt. 2. Oral anticoagulants Circulation. 89:1994;1469-1480.
12. Schulman S., Rhedin A.S., Lindmarker P., Carlsson A., Larfars G., Nicol P., Loogna E., Svensson E., Ljungberg B., Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 332:1995;1661-1665.
13. Levine M.N., Hirsh J., Gent M., Turpie A.G., Weitz J., Ginsberg J., Geerts W., Leclerc J., Neemeh J., Powers P., Piovella F. Optimal duration of oral anticoagulant therapy. A randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis Thromb Haemost. 74:1995;606-611.
14. Hull R.D., Carter C.J., Jay R.M., Ockelford P.A., Hirsh J., Turpie A.G., Zielinsky A., Gent M., Powers P.J. The diagnosis of acute, recurrent, deep-vein thrombosis. A diagnostic challenge Circulation. 67:1983;901-906.
15. Eichinger S., Stumpflen A., Hirschl M., Bialonczyk C., Herkner K., Stain M., Schneider B., Pabinger I., Lechner K., Kyrle P.A. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost. 80:1998;566-569.
16. Brandjes D.P., Büller H.R., Heijboer H., Huisman M.V., de Rijk M., Jagt H., ten Cate J.W. Randomised trial of effect of compression stocking in patients with symptomatic proximal-vein thrombosis. Lancet. 349:1997;759-762.
17. Hull R.D., Raskob G.E., Hirsh J., Jay R.M., Leclerc J.R., Geerts W.H., Rosenbloom D., Sackett D.L., Anderson C., Harrison L., Gent M. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 315:1986;1109-1114.
18. Hull R.D., Delmore T., Genton E., Hirsh J., Gent M., Sackett D., Mcloughlin D., Armstrong P. Warfarin sodium versus low-dose heparin in the treatment of venous thrombosis. N Engl J Med. 301:1979;855-858.
19. Huisman M.V., Buller H.R., ten Cate J.W. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. Arch Intern Med. 148:1988;681-683.
20. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., Carta M., Cattelan A.M., Polistena P., Bernardi E., Prins M.H. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 125:1996;1-7.
21. Prandoni P., Villalta S., Bagatella P., Rossi L., Marchiori A., Piccioli A., Bernardi E., Girolami B., Simioni P., Girolami A. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 82:1997;423-428.
22. Hull R.D., Raskob G.E., Brant R.F., Pineo G.F., Valentine K.A. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 157:1997;2562-2568.
23. Hirsh J., Fuster V. AHA Medical/Scientific Statement. Special Report. Guide to anticoagulant therapy. Part 1. Heparin Circulation. 89:1994;1449-1468.
24. Hirsh J., Levine M.N. Low molecular weight heparin. Blood. 79:1992;1-17.
25. White R.H., Zhou H., Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 128:1998;737-740.
26. Ridker P.M., Miletich J.P., Hennekens C.H., Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 277:1997;1305-1307.
27. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet. 346:1995;1133-1134.